Purdue Pharma’s Plea Deal Won’t Solve America’s Drug Problem

The U.S. was primed for the opioid crisis long before OxyContin was trademarked.

The U.S. was primed for the opioid crisis long before OxyContin was trademarked. Shutterstock

 

Connecting state and local government leaders

COMMENTARY | Billion-dollar fines will never mend the myriad social issues underlying Americans’ voracious appetite for pain relief.

Years ago, after I had two wisdom teeth extracted, my oral surgeon wrote a prescription for OxyContin. The pills fulfilled their objective, but when they were gone, I still had a giant, gaping hole in my mouth. It was hardly surprising. By then, just a few years into a long struggle with addiction, I was well aware of the reason opioids are called pain killers, not wound healers. 

The same might be said of the plea deal that OxyContin maker Purdue Pharma recently struck with the U.S. Justice Department over the company’s role in the opioid epidemic: The guilty plea is a welcome distraction, but it has about as much healing potency as a pain pill.

In exchange for pleading guilty to violating federal anti-kickback laws and defrauding federal health agencies, Purdue Pharma has been ordered to pay an $8 billion penance. The total might as well be $800 gazillion; loopholes make it unlikely that the sum will ever be fully paid. Members of the Sackler family have agreed to pay $225 million in civil penalties and have proposed a separate settlement to resolve thousands of local lawsuits. None of the parties will go to prison. 

The punishments reek of a particular type of hypocrisy that flourishes in the toxic stolons of a drug policy steeped in racist double standards: It underscores the vast disparity between the way our supposedly blind justice system treats white-collar kingpins and the way it treats people like Derek Harris, an African American Gulf War Veteran who was given a life sentence for selling a little more than half a gram of weed to an undercover cop in Louisiana. (Harris was recently released after spending nearly a decade in prison.)

As part of the plea deal, Purdue Pharma will be restructured. Deputy U.S. Attorney General Jeffrey Rosen said the company’s assets will be repurposed “entirely for the public’s benefit.” It will put future proceeds toward opioid abatement and provide life-saving overdose medications for free or at-cost. At the press conference where the terms were disclosed, Rosen emphasized the government’s commitment to reign in the abuse and diversion of pharmaceutical opioids. Noticeably absent from the miasmic stew of restrictions, clampdowns, and accountability measures, however, was anything remotely resembling a plan to address the actual problem: a mental and physical health crisis fueled by economic disparities and exacerbated by drug policies that profoundly disregard science and evidence.

Although opioids take hold with a ferocity unlike any other vice or type of substance, they aren’t recreational drugs. Rather, compulsive opioid use arises from the relief they provide from physical or emotional pain. With each dose, the user’s brain is flooded with dopamine. As in any flood, erosion occurs.

Purdue Pharma’s scientists and executives understood the biological mechanics of their product better than any illicit drug kingpin in history. They preyed on the subjective nature of pain and our hard-wired, human instinct to avoid it. And they were behind successful lobbying initiatives to convince the Joint Commission, one of the nation’s leading health care accreditation organizations, to designate pain as medicine’s “fifth” vital sign. 

But the U.S. was primed for the opioid crisis long before OxyContin was trademarked. We have long been among the world’s biggest consumers of illicit drugs. We are an instant gratification society, beset by high rates of depression, anxiety, and trauma and saddled with inadequate drug prevention, addiction treatment, and mental health resources. Purdue Pharma’s guilty plea not only won’t change that, it will reinforce our misguided response to this national health emergency — a response that has directed just 5 percent of annual drug control spending toward prevention and just 36 percent toward treatment. The rest is burned on law enforcement and intercepting the drug trade, as well as international operations.

Among many tragic ironies of the Purdue Pharma outcome is that, for the U.S. to overcome the opioid epidemic, regulations on pharmaceutical opioids will need to be loosened, not tightened. Methadone and buprenorphine, the only medications proven to dramatically cut the risk of overdose fatality, are among the most restricted legal substances in the Drug Enforcement Administration’s decidedly unscientific scheduling system. Overregulation of prescription opioid medications have forced many people to choose between suffering in pain or rolling the dice in an illicit market saturated with increasingly potent fentanyl analogues.

A century ago, addiction was widely believed to be an incurable moral failure on the part of the user. Today, we know it is a complex medical condition, with usage and overdose rates often correlating with unemployment and struggling economies. Although villains like Purdue Pharma and members of the Sackler family more than deserve our vitriol and the harshest of medieval punishments for their heinous crimes, such vengeance will merely satisfy our hunger for a pound of flesh, while doing nothing to solve the myriad social issues that underlie our voracious appetite for pain relief. 

Even if we were to completely eradicate opioid use, we’d still be left with an epidemic of untreated pain and anguish. When will we address that?

This article was originally published on Undark. Read the original article.

David Poses is a writer, speaker, and activist on evidence-based drug policy and treatment. He is the author of the upcoming memoir, “The Weight of Air.”

NEXT STORY: Report: State Election Officials Find No Evidence of Fraud

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.